Berlex names new CEO
Executive Summary
Reinhard Franzen becomes Berlex president and CEO effective April 1. Franzen has served as COO since Jan. 1 after holding the position of VP and general manager of Berlex' women's health business. Franzen replaces Dale Stringfellow, PhD, who will remain as chairman of Collateral Therapeutics, which Berlex recently acquired...